🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Prestige BioPharma Limited (KRX:950210)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,690.00
-185.00 (-4.77%)
Nov 20, 2026, 3:30 PM KST

Prestige BioPharma Revenue

In the fiscal year ending June 30, 2026, Prestige BioPharma had annual revenue of 26.07B KRW with 81.99% growth. Prestige BioPharma had revenue of 15.39B in the quarter ending June 30, 2026, with 178.46% growth. That makes Prestige BioPharma the 34,104th largest company in the world by revenue and 2,173rd in South Korea.

Revenue
26.07B
Revenue Growth
+81.99%
P/S Ratio
1.70
Revenue / Employee
407.37M
Employees
64
Market Cap
44.35B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202626.07B11.75B81.99%
Jun 30, 202514.33B13.64B1,978.97%
Jun 30, 2024689.08M527.23M325.77%
Jun 30, 2023161.84M--
Jun 30, 2022---
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.